Intratympanic Methylprednisolone for Sudden Sensorineural Hearing Loss: Comprehensive Re Examination of the Model

@article{Piones2015IntratympanicMF,
  title={Intratympanic Methylprednisolone for Sudden Sensorineural Hearing Loss: Comprehensive Re Examination of the Model},
  author={Jeanette S{\'a}enz Pi{\~n}ones and Ithzel Mar{\'i}a Villarreal and Raimon Garc{\'i}a Chiller{\'o}n and Trinidad and Rafael Ram{\'i}rez‐Camacho and Jos{\'e} Ram{\'o}n Garc{\'i}a-Berrocal},
  journal={Journal of Otolaryngology-ENT Research},
  year={2015},
  volume={3}
}
Objective: To evaluate the effectiveness and safety of Intratympanic methylprednisolone injection in patients with sudden sensorineural hearing loss (SSNHL) by means of a comparison between subjective and objective outcomes and a review of the literature regarding methylprednisolone transtympanic administration. Data Sources: An electronic database search (MEDLINE and PubMed) was performed with the objective of identifying all studies published in the English language between January 1980 and… 
6 Citations

Tables from this paper

Can sudden sensorineural hearing loss predict stroke? A long-term study
TLDR
There seems to be a relationship between SHL and stroke, especially in patients with cardiovascular risk factors, and a longer follow-up is recommended since stroke may develop several years after the onset of the hearing loss episode.

References

SHOWING 1-10 OF 66 REFERENCES
Intratympanic Steroids for Sudden Sensorineural Hearing Loss
  • Samuel A. Spear, S. Schwartz
  • Medicine
    Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
  • 2011
TLDR
Intratympanic steroid treatment as primary treatment for sudden sensorineural hearing loss appears equivalent to treatment with high-dose oral prednisone therapy, and as salvage therapy, intratYmpanic steroids offer the potential for some degree of additional hearing recovery, although it remains uncertain if this improvement is clinically significant and what percentage of patients is likely to show benefit.
Intratympanic methylprednisolone as rescue therapy in sudden sensorineural hearing loss.
TLDR
Three intratympanic injections of methylprednisolone improved pure-tone average or speech discrimination scores for a subset of sudden hearing loss subjects that failed to benefit from oral steroids.
Intratympanic Methylprednisolone for Sudden Sensorineural Hearing Loss
  • R. Kılıç, M. A. Şafak, L. Özlüoğlu
  • Medicine
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
  • 2007
TLDR
IT methylprednisolone injection provides more significant hearing improvement for patients that failed with previous high-dose systemic corticosteroid administration than systemic cortiosteroid treatment alone, and may be the first-step medical treatment of idiopathic SSHL alone or at least may be combined with the systemic Corticosteroids administration.
Intratympanic Methylprednisolone in Refractory Sudden Hearing Loss: A 27-Patient Case Series With Univariate and Multivariate Analysis
  • I. Dallan, A. De Vito, A. Nacci
  • Medicine
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
  • 2010
TLDR
The experience seems to confirm the usefulness (at least in 50% of patients) of local steroids administration in cases of refractory sudden sensorineural hearing loss, and encouraging data strongly call for further and serious evaluation through randomized studies.
Early Posttreatment Audiometry Underestimates Hearing Recovery after Intratympanic Steroid Treatment of Sudden Sensorineural Hearing Loss
TLDR
Recovery from ISSNHL after ITS injections occurs more frequently >5 weeks after initiating ITS, may be due to the natural history of sudden hearing loss or the prolonged effect of steroid in the inner ear.
Intratympanic Methylprednisolone Improves Hearing Function in Refractory Sudden Sensorineural Hearing Loss: A Control Study
TLDR
IT steroid therapy can improve hearing function in patients with SSNHL after the failure of systemic steroid treatment, and this treatment was significantly better than that in the other two groups.
Endoscopic intratympanic methylprednisolone injection for treatment of refractory sudden sensorineural hearing loss and one case in pregnancy.
OBJECTIVE to evaluate the effectiveness of transtympanic methylprednisolone injection in patients with refractory sudden sensorineural hearing loss via endoscopic diode laser myringotomy. SUBJECTS
Intratympanic Steroids for Idiopathic Sudden Sensorineural Hearing Loss
TLDR
Findings support the use of IT steroids as an early intervention in the treatment of ISSHL and identify “prompt treatment” as the only variable that significantly affected the outcome.
Intratympanic prednisolone therapy for sudden sensorineural hearing loss: A new protocol
TLDR
Intratympanic administration of prednisolone at a dose of 62.5 mg/ml performed every day for 3 consecutive days is more efficacious than the therapeutic approaches described so far in the literature.
Intratympanic Corticosteroids for Sudden Idiopathic Sensorineural Hearing Loss
  • A. Banerjee, L. Parnes
  • Medicine
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
  • 2005
TLDR
Instillation of intratympanic steroids represents a safe and potentially effective treatment of sudden idiopathic sensorineural hearing loss and those treated within 10 days of onset had a statistically significant better outcome.
...
1
2
3
4
5
...